MLYS logo

Mineralys Therapeutics (MLYS) Cash From Investing

Annual CFI

$114.96 M
+$275.43 M+171.64%

December 31, 2024


Summary


Performance

MLYS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

Quarterly CFI

$83.57 M
+$3.96 M+4.98%

December 31, 2024


Summary


Performance

MLYS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

TTM CFI

$114.96 M
+$91.66 M+393.39%

December 31, 2024


Summary


Performance

MLYS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MLYS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+171.6%+1133.1%+171.6%
3 y3 years+100.0%+1133.1%+171.6%
5 y5 years-+1133.1%+171.6%

MLYS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+171.6%at high+159.6%at high+164.5%
5 y5-yearat high+171.6%at high+159.6%at high+164.5%
alltimeall timeat high+171.6%at high+159.6%at high+164.5%

Mineralys Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$114.96 M(-171.6%)
$83.57 M(+5.0%)
$114.96 M(+393.4%)
Sep 2024
-
$79.61 M(+929.0%)
$23.30 M(-144.6%)
Jun 2024
-
$7.74 M(-113.8%)
-$52.30 M(-31.3%)
Mar 2024
-
-$55.95 M(+591.7%)
-$76.17 M(-52.5%)
Dec 2023
-$160.47 M
-$8.09 M(-301.9%)
-$160.47 M(+56.7%)
Sep 2023
-
$4.01 M(-124.8%)
-$102.38 M(-42.5%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$16.14 M(-88.5%)
-$178.15 M(+10.0%)
Mar 2023
-
-$140.25 M(-380.5%)
-$162.01 M(+644.6%)
Dec 2022
-$21.76 M(<-9900.0%)
$50.00 M(-169.7%)
-$21.76 M(-69.7%)
Sep 2022
-
-$71.76 M(<-9900.0%)
-$71.76 M(<-9900.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2022
-
$0.00
$0.00
Dec 2021
$0.00
-
-

FAQ

  • What is Mineralys Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual CFI year-on-year change?
  • What is Mineralys Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly CFI year-on-year change?
  • What is Mineralys Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Mineralys Therapeutics?
  • What is Mineralys Therapeutics TTM CFI year-on-year change?

What is Mineralys Therapeutics annual cash flow from investing activities?

The current annual CFI of MLYS is $114.96 M

What is the all time high annual CFI for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual cash flow from investing activities is $114.96 M

What is Mineralys Therapeutics annual CFI year-on-year change?

Over the past year, MLYS annual cash flow from investing activities has changed by +$275.43 M (+171.64%)

What is Mineralys Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of MLYS is $83.57 M

What is the all time high quarterly CFI for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly cash flow from investing activities is $83.57 M

What is Mineralys Therapeutics quarterly CFI year-on-year change?

Over the past year, MLYS quarterly cash flow from investing activities has changed by +$91.66 M (+1133.13%)

What is Mineralys Therapeutics TTM cash flow from investing activities?

The current TTM CFI of MLYS is $114.96 M

What is the all time high TTM CFI for Mineralys Therapeutics?

Mineralys Therapeutics all-time high TTM cash flow from investing activities is $114.96 M

What is Mineralys Therapeutics TTM CFI year-on-year change?

Over the past year, MLYS TTM cash flow from investing activities has changed by +$275.43 M (+171.64%)